How is Stem Cell Treatment for Traumatic Brain Injury done?
At Stem Cell Mexico, stem cell treatment for traumatic brain injury (TBI) is a structured, minimally invasive process rather than a single injection.

It starts with a review of your brain imaging, neurology and rehabilitation reports and a consultation with the doctor; continues with laboratory testing and an in-person evaluation on arrival; and centers on the application of allogeneic mesenchymal stromal cells (MSCs) derived exclusively from Wharton's jelly (donated umbilical cord tissue), most commonly by slow intravenous (IV) infusion under medical monitoring. Most patients stay overnight under nursing supervision and have a check-up before going home, followed by structured follow-up over the next months. The treatment does not involve brain surgery, and it is designed to complement, not replace, rehabilitation. Each step is adapted to the person's injury, current abilities and support needs.
This guide walks you through each stage, explains why each step matters and describes what patients and families can expect.
Why the process starts long before the procedure
A traumatic brain injury can affect movement, speech, memory, attention, mood, sleep and energy, and every injury is different. To decide whether regenerative treatment is reasonable, and how to plan it safely, the medical team needs to understand:
- The type of injury (for example, diffuse axonal injury, contusions or hemorrhage) and any surgeries, such as craniectomy or shunt placement.
- How long ago the injury occurred and how recovery has progressed.
- Current symptoms and functional limitations.
- Seizure history and medications.
- Other conditions, such as heart disease, diabetes or infections.
- Support needs during travel and the stay.
A typical itinerary
A common itinerary for a TBI protocol looks like this. Day 1: pickup in the San Diego area in the morning, border crossing with the driver, laboratory tests and in-person consultation, then rest at a nearby hotel or at the clinic depending on your needs. Day 2: cell application by IV infusion, followed by an overnight stay under nursing supervision. Day 3: check-up with the doctor, discharge instructions and return to San Diego, usually in time for an evening flight. Patients with greater support needs may have an additional night of observation, and families can request accommodations such as wheelchair-accessible transport or quieter rooms for patients sensitive to light and noise. The exact itinerary is confirmed in your written plan.
Step 1: Records review
You or your family send recent brain imaging reports (MRI or CT), neurology notes, rehabilitation evaluations and a complete medication list. If available, therapist assessments and standardized scores help establish a baseline.
Step 2: Consultation with the doctor
A complimentary phone or video consultation allows the doctor to understand your goals, explain what regenerative treatment can and cannot do for TBI, and confirm whether you may be a candidate. Goals are made specific, for example improving hand function, walking endurance, fatigue or engagement in therapy, so progress can be measured later.
Step 3: Written plan and preparation
If treatment is appropriate, you receive a written plan describing the cell dose, route, itinerary, inclusions and costs. Preparation instructions typically include:
- Pausing anti-inflammatory painkillers, alcohol, tobacco and cannabis about seven days before treatment, and supplements such as omega 3, turmeric and ginger about five days before.
- Continuing anti-seizure medications and other essential medications on schedule.
- Arriving fasting on the morning of the procedure.
- Planning accessible transportation, mobility support and a companion if needed.
Step 4: Arrival and evaluation
On arrival, you have blood tests, including a complete blood count, metabolic panel, urinalysis and tumor markers, and an in-person evaluation with the doctor. Vital signs and neurological status are recorded. If anything suggests treatment would not be safe that day, such as an infection, it is postponed.
Step 5: The cell application
The cells
Stem Cell Mexico uses only allogeneic MSCs derived from Wharton's jelly. They are prepared by a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.
The route
For TBI, the most common route at our clinic is intravenous infusion:
- A small IV catheter is placed in your arm.
- Baseline vital signs are recorded.
- The cells are infused slowly, usually over 30 to 60 minutes.
- Blood pressure, heart rate, oxygen and temperature are monitored during and after the infusion.
IV delivery avoids neurosurgery. After infusion, many cells are temporarily filtered by the lungs, and their effects on the brain are believed to occur largely through circulating anti-inflammatory and neurotrophic signals and through interactions with the immune system. A review in Frontiers in Immunology (Caplan and colleagues, 2019) describes how different routes, including IV, intra-arterial, intrathecal and direct implantation, change where cells go and how long they stay.
Other routes in research
Some TBI trials have used other routes. In the STEMTRA trial published in Neurology, modified bone-marrow-derived MSCs were implanted surgically around the injured brain tissue in people with chronic TBI, and patients showed greater motor improvement than with sham surgery. That approach requires neurosurgery and is available only through specific research and regulatory pathways; its results apply to that product and route.
Step 6: Observation
Most patients stay overnight under nursing and medical supervision. The team monitors for fever, headache, changes in blood pressure and any neurological changes. Seizure precautions are in place for patients with a history of seizures, and fall prevention measures are used for patients with balance problems.
Step 7: Discharge and recovery
Before discharge, the doctor reviews how you feel and gives written instructions. Common recovery guidance includes:
- Rest on the day of treatment and the following day.
- Expect possible mild fever, headache or fatigue for a day or two.
- Avoid alcohol for at least two weeks and continue avoiding anti-inflammatory painkillers and supplements as instructed.
- Resume rehabilitation gradually after the first days, unless advised otherwise.
Step 8: Follow-up and measurement
Follow-up calls track your progress, typically over three to six months and beyond. Changes are compared with your baseline using therapist assessments, standardized scales, symptom diaries and videos. Families are encouraged to share their observations, since they often notice changes first.
Recovery is gradual, and each person responds differently. Some patients begin noticing changes within the first weeks, while others notice them over the following months, which is why our team stays in contact after treatment to follow your progress and decide whether a second application could help.
How family members can help
Family members and caregivers play an important role throughout the process. Before treatment, they can help gather records, describe the patient's baseline abilities and record short videos of walking, speech or hand use. During the stay, they can share information about communication preferences, fatigue patterns and behaviors that signal discomfort. After treatment, they can keep a simple diary of changes in energy, mood, sleep, participation in therapy and daily activities, which is often more informative than the patient's own recollection, especially when memory or awareness are affected. Including caregivers in follow-up calls helps ensure that instructions are understood and that observations reach the medical team.
The role of rehabilitation
The U.S. National Institute of Neurological Disorders and Stroke (NINDS) emphasizes that rehabilitation is central to TBI recovery. Regenerative treatment is thought to support the brain's environment for repair and plasticity, and rehabilitation is what helps the brain turn that environment into functional gains. For this reason, we encourage patients to continue, and ideally intensify, physical, occupational, speech and cognitive therapy after treatment.
What the evidence says
Evidence for cell therapy in TBI is promising. The STEMTRA trial showed that a specific surgically implanted MSC product improved motor function in chronic TBI, and Japan granted that product conditional, time-limited approval in 2024. Studies of IV and other routes report acceptable safety and improvement in some patients. Large safety analyses of IV MSCs, including a 2026 review of 42 randomized trials of umbilical cord MSCs in Stem Cells Translational Medicine (Hum and colleagues), found temporary fever as the main side effect, without increased infection, thrombosis, cancer or death.
Regulatory context
The FDA has not approved stem cell products for TBI. In Mexico, establishments that handle stem cells operate under sanitary licenses from COFEPRIS.
Who may be a candidate
- Medically stable after TBI, with controlled seizures if present.
- No pending neurosurgery, active infection or cancer within the past five years.
- Clear goals and access to ongoing rehabilitation.
- A companion or caregiver when needed.
- Realistic expectations about gradual, partial improvements rather than a cure.
Questions to ask during your evaluation
- Which route will be used, and why?
- How many cells will I receive?
- How will seizures, medications and mobility needs be handled during my stay?
- How will progress be measured?
- How should I coordinate with my neurologist and therapists?
Bottom line
Stem cell treatment for traumatic brain injury at Stem Cell Mexico follows a step-by-step process: records review, consultation, preparation, evaluation, IV application of Wharton's jelly MSCs with monitoring, observation and structured follow-up, always alongside rehabilitation. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your injury, goals and medical history.
References
- National Institute of Neurological Disorders and Stroke (NINDS, NIH): Traumatic brain injury (opens in a new tab)
- Kawabori M et al. Mesenchymal stromal cell implants for chronic motor deficits after traumatic brain injury (STEMTRA trial). Neurology, 2024 (opens in a new tab)
- Caplan H, Olson SD, Cox CS Jr et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application. Frontiers in Immunology, 2019 (opens in a new tab)
- Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)
